These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 14559831
1. An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Lu J, Pierron A, Ravid K. Cancer Res; 2003 Oct 01; 63(19):6413-23. PubMed ID: 14559831 [Abstract] [Full Text] [Related]
2. An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines. Panjehpour M, Karami-Tehrani F. Int J Biochem Cell Biol; 2004 Aug 01; 36(8):1502-9. PubMed ID: 15147729 [Abstract] [Full Text] [Related]
3. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S, Krishnan AV, Feldman D. Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825 [Abstract] [Full Text] [Related]
4. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line. Amlal H, Faroqui S, Balasubramaniam A, Sheriff S. Cancer Res; 2006 Apr 01; 66(7):3706-14. PubMed ID: 16585197 [Abstract] [Full Text] [Related]
5. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Kim SJ, Min HY, Chung HJ, Park EJ, Hong JY, Kang YJ, Shin DH, Jeong LS, Lee SK. Cancer Lett; 2008 Jun 18; 264(2):309-15. PubMed ID: 18321638 [Abstract] [Full Text] [Related]
6. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Mlejnek P, Dolezel P. Acta Physiol (Oxf); 2010 Jun 18; 199(2):171-9. PubMed ID: 20121715 [Abstract] [Full Text] [Related]
7. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J, Slivova V, Sliva D. Int J Oncol; 2006 Sep 18; 29(3):695-703. PubMed ID: 16865287 [Abstract] [Full Text] [Related]
8. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A. J Cell Physiol; 2009 Nov 18; 221(2):378-86. PubMed ID: 19562684 [Abstract] [Full Text] [Related]
10. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells. Cassoni P, Catalano MG, Sapino A, Marrocco T, Fazzari A, Bussolati G, Fortunati N. Int J Oncol; 2002 Aug 18; 21(2):375-8. PubMed ID: 12118334 [Abstract] [Full Text] [Related]
12. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Lee EJ, Min HY, Chung HJ, Park EJ, Shin DH, Jeong LS, Lee SK. Biochem Pharmacol; 2005 Sep 15; 70(6):918-24. PubMed ID: 16051194 [Abstract] [Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
15. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S. Exp Cell Res; 2001 Oct 01; 269(2):230-6. PubMed ID: 11570815 [Abstract] [Full Text] [Related]
17. Stimulation of estrogen receptor signaling by gamma synuclein. Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J, Shi YE. Cancer Res; 2003 Jul 15; 63(14):3899-903. PubMed ID: 12873981 [Abstract] [Full Text] [Related]
18. Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII. Yuan K, Bai GY, Park WH, Kim SZ, Kim SH. Peptides; 2008 Dec 15; 29(12):2216-24. PubMed ID: 18838091 [Abstract] [Full Text] [Related]
20. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM. J Steroid Biochem Mol Biol; 2005 Feb 15; 94(1-3):71-81. PubMed ID: 15862952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]